These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37779081)

  • 1. Celecoxib-Loaded Self-micellizing Solid Dispersion Suppresses Its Delayed Absorption in Rats with Impaired Gastrointestinal Motility.
    Ogino M; Yakushiji K; Suzuki H; Yamauchi Y; Seto Y; Sato H; Onoue S
    Chem Pharm Bull (Tokyo); 2023; 71(10):787-791. PubMed ID: 37779081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Emulsifying Drug Delivery System of Celecoxib for Avoiding Delayed Oral Absorption in Rats with Impaired Gastric Motility.
    Yakushiji K; Sato H; Ogino M; Suzuki H; Seto Y; Onoue S
    AAPS PharmSciTech; 2020 May; 21(5):135. PubMed ID: 32419073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical and biopharmaceutical characterization of celecoxib nanoparticle: Avoidance of delayed oral absorption caused by impaired gastric motility.
    Yakushiji K; Ogino M; Suzuki H; Seto Y; Sato H; Onoue S
    Int J Pharm; 2018 Dec; 552(1-2):453-459. PubMed ID: 30253211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved oral absorption profile of itraconazole in hypochlorhydria by self-micellizing solid dispersion approach.
    Kojo Y; Matsunaga S; Suzuki H; Sato H; Seto Y; Onoue S
    Eur J Pharm Sci; 2017 Jan; 97():55-61. PubMed ID: 27810562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-micellizing solid dispersion of tacrolimus: Physicochemical and pharmacokinetic characterization.
    Makino K; Tsukada R; Kambayashi A; Yamada K; Sato H; Onoue S
    Biopharm Drug Dispos; 2023 Dec; 44(6):387-395. PubMed ID: 37526477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoidance of food effect on oral absorption profile of itraconazole by self-micellizing solid dispersion approach.
    Kojo Y; Kobayashi K; Matsunaga S; Suzuki H; Seto Y; Sato H; Onoue S
    Drug Metab Pharmacokinet; 2017 Oct; 32(5):273-276. PubMed ID: 28923421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-micellizing solid dispersion of thymoquinone with enhanced biopharmaceutical and nephroprotective effects.
    Halder S; Afrose S; Shill MC; Sharmin N; Mollick PP; Shuma ML; Muhit MA; Rahman SMA
    Drug Deliv; 2024 Dec; 31(1):2337423. PubMed ID: 38590120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-micellizing solid dispersions enhance the properties and therapeutic potential of fenofibrate: Advantages, profiles and mechanisms.
    Shi NQ; Zhang Y; Li Y; Lai HW; Xiao X; Feng B; Qi XR
    Int J Pharm; 2017 Aug; 528(1-2):563-577. PubMed ID: 28602799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-micellizing solid dispersion of cyclosporine A with improved dissolution and oral bioavailability.
    Onoue S; Suzuki H; Kojo Y; Matsunaga S; Sato H; Mizumoto T; Yuminoki K; Hashimoto N; Yamada S
    Eur J Pharm Sci; 2014 Oct; 62():16-22. PubMed ID: 24836392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced biopharmaceutical effects of tranilast on experimental colitis model with use of self-micellizing solid dispersion technology.
    Kojo Y; Suzuki H; Kato K; Kaneko Y; Yuminoki K; Hashimoto N; Sato H; Seto Y; Onoue S
    Int J Pharm; 2018 Jul; 545(1-2):19-26. PubMed ID: 29702241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.
    Shi NQ; Wang SR; Zhang Y; Huo JS; Wang LN; Cai JH; Li ZQ; Xiang B; Qi XR
    Eur J Pharm Sci; 2019 Mar; 130():78-90. PubMed ID: 30684657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-micellizing solid dispersion of cyclosporine A for pulmonary delivery: Physicochemical, pharmacokinetic and safety assessments.
    Suzuki H; Ueno K; Mizumoto T; Seto Y; Sato H; Onoue S
    Eur J Pharm Sci; 2017 Jan; 96():107-114. PubMed ID: 27634579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amorphous Solid Dispersion of Meloxicam Enhanced Oral Absorption in Rats With Impaired Gastric Motility.
    Suzuki H; Yakushiji K; Matsunaga S; Yamauchi Y; Seto Y; Sato H; Onoue S
    J Pharm Sci; 2018 Jan; 107(1):446-452. PubMed ID: 28551427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategic application of self-micellizing solid dispersion technology to respirable powder formulation of tranilast for improved therapeutic potential.
    Suzuki H; Kojo Y; Yakushiji K; Yuminoki K; Hashimoto N; Onoue S
    Int J Pharm; 2016 Feb; 499(1-2):255-262. PubMed ID: 26748364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
    Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
    Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleation During Storage Impeded Supersaturation in the Dissolution Process of Amorphous Celecoxib.
    Song J; Kawakami K
    Mol Pharm; 2023 Aug; 20(8):4050-4057. PubMed ID: 37413788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of meloxicam salts with improved dissolution and pharmacokinetic behaviors in rats with impaired gastric motility.
    Ochi M; Inoue R; Yamauchi Y; Yamada S; Onoue S
    Pharm Res; 2013 Feb; 30(2):377-86. PubMed ID: 22983645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.
    Rashid R; Kim DW; Yousaf AM; Mustapha O; Fakhar Ud Din ; Park JH; Yong CS; Oh YK; Youn YS; Kim JO; Choi HG
    Int J Nanomedicine; 2015; 10():6147-59. PubMed ID: 26491288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous carbon with spherical pores as a carrier for celecoxib with needle-like crystallinity: improve dissolution rate and bioavailability.
    Zhu W; Zhao Q; Sun C; Zhang Z; Jiang T; Sun J; Li Y; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():13-20. PubMed ID: 24863191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.
    Tan A; Davey AK; Prestidge CA
    Pharm Res; 2011 Sep; 28(9):2273-87. PubMed ID: 21560021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.